Glenmark Pharmaceuticals Limited (GLENMARK.NS)
INR 1541.1
(1.08%)
INR 1541.1
(1.08%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -15.01 Billion INR | -605.2% |
| 2022 | 2.97 Billion INR | -68.44% |
| 2021 | 9.41 Billion INR | -2.92% |
| 2020 | 9.7 Billion INR | 25.01% |
| 2019 | 7.75 Billion INR | -12.97% |
| 2018 | 8.91 Billion INR | 15.17% |
| 2017 | 7.74 Billion INR | -15.48% |
| 2016 | 9.15 Billion INR | 30.46% |
| 2015 | 7.02 Billion INR | 47.71% |
| 2014 | 4.75 Billion INR | -12.35% |
| 2013 | 5.42 Billion INR | -11.79% |
| 2012 | 6.14 Billion INR | 32.4% |
| 2011 | 4.64 Billion INR | 1.41% |
| 2010 | 4.57 Billion INR | 38.3% |
| 2009 | 3.31 Billion INR | 71.1% |
| 2008 | 1.93 Billion INR | -69.39% |
| 2007 | 6.32 Billion INR | 103.87% |
| 2006 | 3.1 Billion INR | 252.44% |
| 2005 | 879.76 Million INR | -17.89% |
| 2004 | 1.07 Billion INR | 159.04% |
| 2003 | 413.6 Million INR | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | 3.4 Billion INR | 127.93% |
| 2023 Q4 | -12.18 Billion INR | -246.72% |
| 2023 Q1 | 1.49 Billion INR | 135.01% |
| 2023 Q2 | -819.45 Million INR | -154.66% |
| 2023 Q3 | -3.51 Billion INR | -328.79% |
| 2023 FY | -15.01 Billion INR | -605.2% |
| 2022 FY | 2.97 Billion INR | -68.44% |
| 2022 Q4 | -4.28 Billion INR | -257.13% |
| 2022 Q1 | 1.92 Billion INR | 23.75% |
| 2022 Q2 | 2.6 Billion INR | 35.27% |
| 2022 Q3 | 2.72 Billion INR | 4.66% |
| 2021 Q4 | 1.55 Billion INR | -29.89% |
| 2021 Q1 | 3.06 Billion INR | 31.08% |
| 2021 Q2 | 2.57 Billion INR | -15.95% |
| 2021 FY | 9.41 Billion INR | -2.92% |
| 2021 Q3 | 2.21 Billion INR | -13.88% |
| 2020 Q4 | 2.33 Billion INR | -5.73% |
| 2020 Q3 | 2.48 Billion INR | 6.01% |
| 2020 Q1 | 2.54 Billion INR | 15.31% |
| 2020 FY | 9.7 Billion INR | 25.01% |
| 2020 Q2 | 2.34 Billion INR | -7.88% |
| 2019 Q1 | 1.09 Billion INR | -30.08% |
| 2019 Q3 | 1.9 Billion INR | -25.32% |
| 2019 Q2 | 2.55 Billion INR | 133.84% |
| 2019 FY | 7.75 Billion INR | -12.97% |
| 2019 Q4 | 2.2 Billion INR | 15.44% |
| 2018 Q4 | 1.56 Billion INR | 34.33% |
| 2018 FY | 8.91 Billion INR | 15.17% |
| 2018 Q3 | 1.16 Billion INR | -71.9% |
| 2018 Q2 | 4.14 Billion INR | 77.69% |
| 2018 Q1 | 2.32 Billion INR | 54.26% |
| 2017 Q4 | 1.51 Billion INR | 61.61% |
| 2017 Q2 | 2.04 Billion INR | -38.72% |
| 2017 FY | 7.74 Billion INR | -15.48% |
| 2017 Q1 | 3.33 Billion INR | 1477.02% |
| 2017 Q3 | 934.58 Million INR | -54.26% |
| 2016 Q4 | 211.4 Million INR | -95.4% |
| 2016 Q3 | 4.59 Billion INR | 109.62% |
| 2016 Q2 | 2.19 Billion INR | 0.56% |
| 2016 Q1 | 2.18 Billion INR | 52.5% |
| 2016 FY | 9.15 Billion INR | 30.46% |
| 2015 Q3 | 1.7 Billion INR | -13.9% |
| 2015 FY | 7.02 Billion INR | 47.71% |
| 2015 Q1 | 1.9 Billion INR | 1699.4% |
| 2015 Q2 | 1.97 Billion INR | 3.57% |
| 2015 Q4 | 1.43 Billion INR | -16.01% |
| 2014 Q2 | 1.65 Billion INR | -10.68% |
| 2014 Q4 | 106.13 Million INR | -90.75% |
| 2014 FY | 4.75 Billion INR | -12.35% |
| 2014 Q3 | 1.14 Billion INR | -30.48% |
| 2014 Q1 | 1.84 Billion INR | 329.22% |
| 2013 Q3 | 2.16 Billion INR | 40.14% |
| 2013 FY | 5.42 Billion INR | -11.79% |
| 2013 Q4 | 430.66 Million INR | -80.08% |
| 2013 Q1 | 1.28 Billion INR | -22.86% |
| 2013 Q2 | 1.54 Billion INR | 19.91% |
| 2012 FY | 6.14 Billion INR | 32.4% |
| 2012 Q4 | 1.66 Billion INR | -21.66% |
| 2012 Q2 | 1.56 Billion INR | 100.26% |
| 2012 Q1 | 782.75 Million INR | -47.94% |
| 2012 Q3 | 2.12 Billion INR | 35.83% |
| 2011 Q3 | 448.24 Million INR | 0.0% |
| 2011 Q4 | 1.5 Billion INR | 235.43% |
| 2011 FY | 4.64 Billion INR | 1.41% |
| 2010 FY | 4.57 Billion INR | 38.3% |
| 2009 FY | 3.31 Billion INR | 71.1% |
| 2008 FY | 1.93 Billion INR | -69.39% |
| 2007 FY | 6.32 Billion INR | 103.87% |
| 2006 FY | 3.1 Billion INR | 252.44% |
| 2005 FY | 879.76 Million INR | -17.89% |
| 2004 FY | 1.07 Billion INR | 159.04% |
| 2003 FY | 413.6 Million INR | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Sigachi Industries Limited | 571.8 Million INR | 2726.203% |
| Ind-Swift Limited | 142.31 Million INR | 10651.868% |
| Bajaj HealthCare Limited | -837.93 Million INR | -1692.114% |
| Sakar Healthcare Limited | 116.7 Million INR | 12966.771% |
| Aurobindo Pharma Limited | 31.72 Billion INR | 147.327% |
| Innova Captab Limited | 943.45 Million INR | 1691.677% |
| Divi's Laboratories Limited | 16 Billion INR | 193.854% |
| AstraZeneca Pharma India Limited | 1.61 Billion INR | 1029.768% |
| Morepen Laboratories Limited | 961.59 Million INR | 1661.636% |
| Mankind Pharma Limited | 19.12 Billion INR | 178.502% |
| Sequent Scientific Limited | -358.69 Million INR | -4086.534% |
| Wanbury Limited | 559.56 Million INR | 2783.644% |
| Laurus Labs Limited | 1.6 Billion INR | 1035.327% |
| Nectar Lifesciences Limited | 49.95 Million INR | 30163.423% |
| Glenmark Life Sciences Limited | 4.7 Billion INR | 418.901% |
| Alembic Limited | 2.68 Billion INR | 659.032% |
| Hikal Limited | 696 Million INR | 2257.569% |
| Alembic Pharmaceuticals Limited | 6.15 Billion INR | 343.849% |
| Neuland Laboratories Limited | 3 Billion INR | 600.424% |
| J. B. Chemicals & Pharmaceuticals Limited | 5.52 Billion INR | 371.732% |
| IOL Chemicals and Pharmaceuticals Limited | 1.34 Billion INR | 1217.063% |
| Themis Medicare Limited | 435.23 Million INR | 3550.223% |
| RPG Life Sciences Limited | 876.6 Million INR | 1813.06% |
| Zydus Lifesciences Limited | 38.59 Billion INR | 138.908% |
| Lupin Limited | 19.14 Billion INR | 178.437% |
| Amrutanjan Health Care Limited | 449.72 Million INR | 3439.073% |
| Wockhardt Limited | -4.63 Billion INR | -224.334% |
| Vaishali Pharma Limited | 7.18 Million INR | 208984.129% |
| Aarti Pharmalabs Limited | 2.16 Billion INR | 792.326% |
| Jagsonpal Pharmaceuticals Limited | 224.63 Million INR | 6785.073% |
| Jubilant Pharmova Limited | 771 Million INR | 2047.689% |
| FDC Limited | 3.05 Billion INR | 591.99% |
| Dr. Reddy's Laboratories Limited | 55.68 Billion INR | 126.968% |
| Kilitch Drugs (India) Limited | 146.01 Million INR | 10384.411% |
| Eris Lifesciences Limited | 3.91 Billion INR | 483.095% |
| Venus Remedies Limited | 284.9 Million INR | 5370.712% |
| ZIM Laboratories Limited | 172.46 Million INR | 8807.139% |
| Bliss GVS Pharma Limited | 754.54 Million INR | 2090.174% |
| Par Drugs and Chemicals Limited | 145.01 Million INR | 10455.617% |
| Caplin Point Laboratories Limited | 4.57 Billion INR | 428.528% |
| Shilpa Medicare Limited | 318.74 Million INR | 4811.234% |
| Albert David Limited | 754.2 Million INR | 2091.071% |
| Ajanta Pharma Limited | 8.16 Billion INR | 283.99% |
| Hester Biosciences Limited | 188.89 Million INR | 8049.96% |
| Suven Pharmaceuticals Limited | 3 Billion INR | 600.088% |
| Solara Active Pharma Sciences Limited | -5.67 Billion INR | -164.662% |
| Gufic Biosciences Limited | 861.35 Million INR | 1843.377% |
| Windlas Biotech Limited | 581.87 Million INR | 2680.762% |
| Procter & Gamble Health Limited | 2 Billion INR | 847.173% |
| Aarey Drugs & Pharmaceuticals Limited | 46.83 Million INR | 32161.8% |
| Mangalam Drugs & Organics Limited | -90.71 Million INR | -16453.325% |
| Granules India Limited | 4.05 Billion INR | 470.499% |
| Aarti Drugs Limited | 1.71 Billion INR | 976.026% |
| Bal Pharma Limited | 73.92 Million INR | 20414.223% |
| Alkem Laboratories Limited | 17.95 Billion INR | 183.623% |
| Sun Pharmaceutical Industries Limited | 95.76 Billion INR | 115.681% |
| Lincoln Pharmaceuticals Limited | 933.04 Million INR | 1709.42% |
| Medicamen Biotech Limited | 109.31 Million INR | 13837.7% |
| Unichem Laboratories Limited | -704.74 Million INR | -2030.802% |
| Bafna Pharmaceuticals Limited | 73.47 Million INR | 20536.696% |
| Biofil Chemicals and Pharmaceuticals Limited | 7.09 Million INR | 211841.117% |
| Valiant Laboratories Limited | 3.19 Million INR | 469958.573% |
| Orchid Pharma Limited | 921.66 Million INR | 1729.299% |
| Medico Remedies Limited | 82.9 Million INR | 18212.244% |
| Ind-Swift Laboratories Limited | 4.2 Billion INR | 456.723% |
| Ipca Laboratories Limited | 5.47 Billion INR | 374.352% |
| Brooks Laboratories Limited | -195.91 Million INR | -7564.739% |
| Syncom Formulations (India) Limited | 253.14 Million INR | 6032.117% |
| Piramal Enterprises Limited | -16.83 Billion INR | 10.802% |
| Torrent Pharmaceuticals Limited | 16.56 Billion INR | 190.66% |
| NATCO Pharma Limited | 13.88 Billion INR | 208.166% |
| Suven Life Sciences Limited | -1.05 Billion INR | -1329.122% |
| Krebs Biochemicals & Industries Limited | -197.28 Million INR | -7511.707% |
| Strides Pharma Science Limited | -706.14 Million INR | -2026.587% |
| Indoco Remedies Limited | 984.6 Million INR | 1625.154% |
| Alpa Laboratories Limited | 167.76 Million INR | 9051.021% |
| Lasa Supergenerics Limited | -217.3 Million INR | -6810.384% |
| Sun Pharma Advanced Research Company Limited | -3.87 Billion INR | -287.814% |